Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

10X Genomics Inc (NQ: TXG )

16.78 +0.45 (+2.76%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 4, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about 10X Genomics Inc

< Previous 1 2 3 4 5 6 7 8 9 Next >
Cathie Wood's Ark Innovation, Genomic ETFs Celebrate 10 Years: How Annual Returns Stack Up Against S&P 500
The Ark Innovation and Ark Genomic ETFs turn ten years old. A look at the annual returns and current top holdings. 
Via Benzinga
Topics ETFs Stocks
Exposures US Equities
These Analysts Boost Their Forecasts On 10x Genomics After Q3 Results
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Looking Into 10x Genomics's Recent Short Interest
Via Benzinga
S&P Moves Lower; Domino's Pizza Posts Mixed Q3 Results
Via Benzinga
Topics Stocks
Exposures US Equities
Where 10x Genomics Stands With Analysts
Via Benzinga
In-Depth Examination Of 11 Analyst Recommendations For 10x Genomics
Via Benzinga
Navigating 11 Analyst Ratings For 10x Genomics
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Crude Oil Surges 3%; Delta Air Lines Posts Downbeat Earnings
Via Benzinga
Exposures Fossil Fuels
Dow Falls Over 100 Points; US Inflation Rate Slows To 2.4% In September
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
10x Genomics Crashes After 'Disruptive' Reorg Upsets Third-Quarter Sales
The company is undergoing a reorganization that has proven more "disruptive" than previously expected. 
Via Investor's Business Daily
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
12 Analysts Assess 10x Genomics: What You Need To Know
Via Benzinga
Gene Sequencing Tech Provider 10x Genomics' Q3 Sales Fall Short On Expectations, But CEO Sees Opportunity Ahead
10x Genomics reported Q3 2024 revenue of $151.7 million, down 1% from last year. Instruments revenue dropped 46%, while consumables grew 10%. CEO Serge Saxonov acknowledged the challenges faced but... 
Via Benzinga
Nasdaq, S&P 500 Futures Slip As September CPI Data Looms, Tesla On Radar Ahead Of Robotaxi Event: Strategist Offers Stock Tips Aligned With Presidential Candidates' Trade Policies
The imminent release of the September consumer price inflation report is keeping sentiment guarded as the index futures trade modestly lower early Thursday. 
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
Why BloomZ Shares Are Trading Higher By Around 64%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Delta Air Lines, Domino's Pizza And 3 Stocks To Watch Heading Into Thursday
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Gold Rally Loses Steam As Treasury Yields Stabilize, Dollar Rebounds: 6 Miner Stocks See Declines On Wednesday
Gold rally loses momentum as dollar rebounds and Treasury yields stabilize. Gold mining stocks also decline due to dip in gold prices. 
Via Benzinga
Cisco Posts Upbeat Earnings, Joins Tesla, Ulta Beauty, Robinhood, Dell And Other Big Stocks Moving Higher On Thursday
Via Benzinga
Starbucks To Rally Around 43%? Here Are 10 Top Analyst Forecasts For Tuesday
Via Benzinga
TXG Stock Earnings: 10x Genomics Beats EPS, Beats Revenue for Q2 2024
TXG stock results show that 10x Genomics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
Cathie Wood-Led Ark Invest Sells $8M In Tesla Shares Despite Bullish Autonomy Forecast
Via Benzinga
Cathie Wood Touts Palantir, Coinbase And Roku As ARK's Flagship Fund Shifts Focus From Mag 6 Amid 'Whiff' Of Lower Interest Rates
In a recent letter to investors, Cathie Wood, the CEO of ARK Invest, highlighted the potential of the company's flagship fund, ARK Innovation ETF, despite its recent underperformance. 
Via Benzinga
Topics ETFs
What's Going On With 10x Genomics Stock On Wednesday?
Illumina acquires Fluent BioSciences to enhance single-cell analysis and multiomics research. 10x Genomics faces challenges as shares drop amid competitive pricing pressures in the single-cell market. 
Via Benzinga
Why SeaStar Medical Holding Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Kura Sushi Posts Weak Q3 Results, Joins LegalZoom.com And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Via Benzinga
Nasdaq, S&P 500 Futures Rise Amid Tech Buoyancy, Bitcoin Gains 2%: Analyst Warns Of Elevated Valuations And Potential Election Volatility
The market’s bullish bias will likely be put to the test on Wednesday as some key market-moving catalysts due this week could pose a threat to the upward momentum. 
Via Benzinga
Topics Stocks
Exposures US Equities
Why VivoPower International Shares Are Trading Higher By Around 31%; Here Are 20 Stocks Moving Premarket
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.